Alemtuzumab as initial therapy for Sezary syndrome: A report of 2 cases. 

 -  2020 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>2352-5126 
<br/><br/><label>Standard No.: </label>10.1016/j.jdcr.2020.07.005 [doi] PMC7452245 [pmc] S2352-5126(20)30493-8 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>IN PROCESS -- NOT YET INDEXED
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Washington Hospital Center<br/>Washington Cancer Institute
<br/><br/><label>Index Terms--Occupation: </label><br/>Dermatology
<br/><br/><label>Index Terms--Function: </label><br/>Case Reports